Pages
Products

Panoply™ Human HDAC2 Over-expressing Stable Cell Line

For research use only. Not intended for any clinical use.

Cat. No. :   CSC-SC006887

Host Cell :   HEK293 (CHO and other cell types are also available) Size :   >1x106 frozen cells/vial

Inquire for Price

Cell Line Information

Cell Culture Information

Safety and Packaging

Gene Information

Cat. No. CSC-SC006887
Description Using Creative Biogene's proprietary lentiviral vectors, we subclone the target gene into lentivector, generate the lentivirus particles, sequentially infect the cell line HEK293 (other cell types are also available according to your requirements), and select the clones constantly expressing target gene at high level.
Target Gene HDAC2
Gene Species Homo sapiens (Human)
Host Cell HEK293 (CHO and other cell types are also available)
Host Cell Species Species varies
Applications

1. Gene expression studies

2. Signaling pathway research

3. Drug screening and toxicology

4. Disease research

Size 2 × 10^6 cells / vial
Stability Validated for at least 10 passages
Quality Control Negative for bacteria, yeast, fungi and mycoplasma.
Storage Liquid nitrogen
Shipping Dry Ice
Revival Rapidly thaw cells in a 37°C water bath. Transfer contents into a tube containing pre-warmed media. Centrifuge cells and seed into a 25 cm2 flask containing pre-warmed media.
Mycoplasma Negative
Format One frozen vial containing millions of cells
Storage Liquid nitrogen
Safety Considerations The following safety precautions should be observed.
1. Use pipette aids to prevent ingestion and keep aerosols down to a minimum.
2. No eating, drinking or smoking while handling the stable line.
3. Wash hands after handling the stable line and before leaving the lab.
4. Decontaminate work surface with disinfectant or 70% ethanol before and after working with stable cells.
5. All waste should be considered hazardous.
6. Dispose of all liquid waste after each experiment and treat with bleach.
Ship Dry ice
Gene Name HDAC2 histone deacetylase 2 [ Homo sapiens ]
Gene Symbol HDAC2
Synonyms HD2; RPD3; YAF1
GeneID 3066
Uni ProtID Q92769
mRNA Refseq NM_001527.3
Protein Refseq NP_001518.3
Chromosome Location 6q21
Function NAD-dependent histone deacetylase activity (H3-K14 specific); NAD-dependent histone deacetylase activity (H3-K18 specific); NAD-dependent histone deacetylase activity (H3-K9 specific); NAD-dependent histone deacetylase activity (H4-K16 specific); chromatin binding; enzyme binding; histone deacetylase activity; protein binding; protein deacetylase activity; sequence-specific DNA binding; transcription factor binding;
Pathway Alcoholism, organism-specific biosystem; Alcoholism, conserved biosystem; Cell cycle, organism-specific biosystem; Cell cycle, organism-specific biosystem; Cell cycle, conserved biosystem; Chronic myeloid leukemia, organism-specific biosystem; Chronic myeloid leukemia, conserved biosystem;
MIM 605164
Quick Inquiry

Case Study

Q & A

Customer Reviews

Invasion and metastasis are the main causes of death in patients with malignant tumors, including gastric cancer. Here, researchers investigated the effects of methionine restriction (MR) on gastric cancer metastasis and its underlying mechanisms. The results showed that MR inhibited the migration, invasion, and lung metastasis of gastric cancer cells. MR increased E-cadherin expression while decreasing H3K27me3 levels in the E-cadherin promoter region. E-cadherin expression in gastric cancer cells was negatively regulated by HDAC2. Overexpression of HDAC2 decreased H3K27Ac levels in the E-cadherin promoter region, while knockdown of HDAC2 increased H3K27Ac levels. Under MR conditions, knockdown of HDAC2 further upregulated E-cadherin expression and inhibited the migration, invasion, and lung metastasis of gastric cancer cells. MR combined with HDAC2 knockdown promoted E-cadherin expression by mediating its methylation and acetylation, thereby inhibiting the invasion, migration, and lung metastasis of gastric cancer cells. These studies provide a new theoretical basis for the inhibitory effect of MR on gastric cancer.

Considering the elevated expression of HDAC2 in gastric cancer and its regulatory role in E-cadherin histone deacetylation, researchers investigated the regulatory effect of HDAC2 on E-cadherin in gastric cancer cells. They constructed HDAC2-overexpressing MKN45 and AGS cells and HDAC2-knockdown MKN45 and AGS cells. qRT-PCR and Western blot analysis showed that E-cadherin expression was suppressed in HDAC2-overexpressing MKN45 and AGS cells, while E-cadherin expression increased in HDAC2-knockdown cells (Figure 1A-C). The researchers also examined apoptosis after HDAC2 knockdown, and the results showed that HDAC2 knockdown did not significantly affect apoptosis in gastric cancer cells. Chromatin immunoprecipitation (ChIP) experiments were performed to confirm that HDAC2 regulates the acetylation of the E-cadherin promoter, using an H3K27ac antibody for immunoprecipitation. The results showed that H3K27ac levels in the E-cadherin promoter region were decreased in HDAC2-overexpressing cells, while H3K27ac levels in the E-cadherin promoter region were increased in HDAC2-knockdown cells (Figure 1D). These data suggest that HDAC2 may inhibit E-cadherin transcription by suppressing the acetylation of the E-cadherin promoter.

Figure 1. The regulatory effect of HDAC2 on the acetylation of the E-cadherin promoter.Figure 1. The regulatory effect of HDAC2 on the acetylation of the E-cadherin promoter. (Li Y, et al., 2023)

Ask a Question

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

Write a Review

Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.

Needs improvement

Satisfaction

General satisfaction

Very satisfaction